Track Provention Bio's inventory ($1.2M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Provention Bio (PRVB) currently reports a inventory of $1.2M as of December 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Provention Bio's inventory history and peer comparisons.
Provention Bio's inventory changed from $0 to $1.2M (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Provention Bio reported $1.2M in inventory as of December 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current inventory of $1.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Provention Bio, and consider following PRVB for alerts when major investors trade the stock.
Provention Bio is classified in the Healthcare sector. On inventory, it currently shows $1.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRVB with unrelated industries.